These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2053556)

  • 1. Controlled multicenter double-blind trial of nicardipine in the treatment of primary Raynaud phenomenon. French Cooperative Multicenter Group for Raynaud Phenomenon, Paris, France.
    Am Heart J; 1991 Jul; 122(1 Pt 2):352-5. PubMed ID: 2053556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nicardipine in the treatment of Raynaud's phenomenon].
    Kahan A; Amor B; Menkès CJ
    Rev Rhum Mal Osteoartic; 1987 Jun; 54(6):487-90. PubMed ID: 3303287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicardipine in the treatment of Raynaud's phenomenon: a randomized double-blind trial.
    Kahan A; Amor B; Menkès CJ; Weber S; Guérin F; Degeorges M
    Angiology; 1987 Apr; 38(4):333-7. PubMed ID: 3555175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicardipine for the treatment of Raynaud's phenomena: a double blind crossover trial of a new calcium entry blocker.
    Rupp PA; Mellinger S; Kohler J; Dorsey JK; Furst DE
    J Rheumatol; 1987 Aug; 14(4):745-50. PubMed ID: 3312603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicardipine in the treatment of Raynaud's phenomenon. Dissociation of platelet activation from vasospasm.
    Wigley FM; Wise RA; Malamet R; Scott TE
    Arthritis Rheum; 1987 Mar; 30(3):281-6. PubMed ID: 2952125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slow-releasing nicardipine in the treatment of Raynaud's phenomena without underlying diseases.
    Ferri C; Cecchetti R; Cini G; Gambini I; La Civita L; Bernini L; Bombardieri S; Pasero G
    Clin Rheumatol; 1992 Mar; 11(1):76-80. PubMed ID: 1582124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind placebo-controlled crossover study of oral nicardipine in the treatment of Raynaud's phenomenon.
    Wollersheim H; Thien T
    J Cardiovasc Pharmacol; 1991 Dec; 18(6):813-8. PubMed ID: 1725892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous nicardipine in Raynaud's phenomenon: a controlled trial.
    van Heereveld H; Wollersheim H; Gough K; Thien T
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):68-74. PubMed ID: 2450259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study.
    Wigley FM; Wise RA; Seibold JR; McCloskey DA; Kujala G; Medsger TA; Steen VD; Varga J; Jimenez S; Mayes M; Clements PJ; Weiner SR; Porter J; Ellman M; Wise C; Kaufman LD; Williams J; Dole W
    Ann Intern Med; 1994 Feb; 120(3):199-206. PubMed ID: 7506013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled multicenter double blind trial of an oral analog of prostacyclin in the treatment of primary Raynaud's phenomenon. French Microcirculation Society Multicentre Group for the Study of Vascular Acrosyndromes.
    Vayssairat M
    J Rheumatol; 1996 Nov; 23(11):1917-20. PubMed ID: 8923366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study.
    Haley EC; Kassell NF; Torner JC
    J Neurosurg; 1993 Apr; 78(4):537-47. PubMed ID: 8450326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicardipine in the treatment of Raynaud's phenomenon.
    Kahan A; Amor B; Menkès CJ
    Arthritis Rheum; 1987 May; 30(5):598. PubMed ID: 3593442
    [No Abstract]   [Full Text] [Related]  

  • 13. A double blind placebo controlled crossover randomized trial of diltiazem in Raynaud's phenomenon.
    Rhedda A; McCans J; Willan AR; Ford PM
    J Rheumatol; 1985 Aug; 12(4):724-7. PubMed ID: 3903157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of nicardipine for chronic, stable angina pectoris: a multicenter randomized trial.
    Scheidt S; LeWinter MM; Hermanovich J; Venkataraman K; Freedman D
    Am J Cardiol; 1986 Oct; 58(9):715-21. PubMed ID: 3094355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous nicardipine for the treatment of severe hypertension. A double-blind, placebo-controlled multicenter trial.
    Wallin JD; Fletcher E; Ram CV; Cook ME; Cheung DG; MacCarthy EP; Townsend R; Saunders E; Davis WR; Langford HG
    Arch Intern Med; 1989 Dec; 149(12):2662-9. PubMed ID: 2688586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No significant effect of ginkgo biloba special extract EGb 761 in the treatment of primary Raynaud phenomenon: a randomized controlled trial.
    Bredie SJ; Jong MC
    J Cardiovasc Pharmacol; 2012 Mar; 59(3):215-21. PubMed ID: 22030896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the calcium channel blocker nifedipine on Raynaud's phenomenon. A controlled double blind trial.
    Sauza J; Kraus A; González-Amaro R; Alarcón-Segovia D
    J Rheumatol; 1984 Jun; 11(3):362-4. PubMed ID: 6376801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled double-blind trial of the clinical effect of nifedipine in the treatment of idiopathic Raynaud's phenomenon.
    Gjørup T; Kelbaek H; Hartling OJ; Nielsen SL
    Am Heart J; 1986 Apr; 111(4):742-5. PubMed ID: 3513504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicardipine in elderly patients with hypertension: a review of experience in France.
    Forette F; McClaran J; Hervy MP; Bouchacourt P; Henry JF
    Am Heart J; 1989 Jan; 117(1):256-61. PubMed ID: 2643285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized double-blind comparison of side effects of nicardipine and nifedipine in angina pectoris. The Nicardipine Investigators Group.
    DeWood MA; Wolbach RA
    Am Heart J; 1990 Feb; 119(2 Pt 2):468-78. PubMed ID: 2405616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.